Wednesday, July 14th, 2010
David Whitcombe, PhD
David Whitcombe is an experienced biotech director who brings a wealth of experience in successfully developing quality diagnostics and in growing biotechnology companies. David was previously part of the successful founding team of DXS, a North West UK based Molecular Diagnostics company which sold to Qiagen in 2009 in a deal worth £80M.
